Genomics pioneer J. Craig Venter co‑founded Diploid Genomics, Inc., unveiling an AI‑driven analytics company backed by Healthier Capital as sole external investor. The new firm will develop advanced genomics processing and interpretation tools aimed at clinical and research applications, combining deep sequencing data with machine learning to generate actionable human genomic insights. The launch signals continued commercialization of high‑throughput genomics combined with AI analytics for precision medicine.